Insiders Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Real-time Estimate Cboe Europe Other stock markets 01:35:26 10/05/2024 pm IST			5-day change	1st Jan Change
111.6 ^SEK	-0.31%		+5.07%	-11.88%

08/05	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	MT
06/05	Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calliditas Therapeutics Announces Executive Changes	07/01	CI
Calliditas Announces Additions to the Management Team, Effective 1 January 2024	01/12	CI
Calliditas Therapeutics' Nomination Committee Composition for the Agm 2024	23/23/23	CI
Calliditas Therapeutics AB Announces Board Changes	30/23/30	CI
Calliditas Therapeutics nomination committee composition for the AGM 2023	24/22/24	AQ
Calliditas Therapeutics' nomination committee composition for the AGM 2023	21/22/21	AQ
Calliditas Therapeutics AB Announces Nomination Committee Composition for the Agm 2023	21/22/21	CI
Calliditas Therapeutics AB Announces Executive Appointments	11/22/11	CI
Calliditas Therapeutics AB Announces Board Changes	19/22/19	CI
Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2022 - Form 6-K	02/21/02	PU
Calliditas Therapeutics? Nomination Committee for the AGM 2022	02/21/02	CI
Calliditas Therapeutics' nomination committee for the AGM 2022	02/21/02	AQ
Calliditas Therapeutics AB Promotes Andrew Udell to President, North America	03/21/03	CI
Calliditas Therapeutics AB Announces Executive Appointments	08/21/08	CI
Calliditas Therapeutics : rsquo; nomination committee for the AGM 2	24/20/24	PU
Calliditas Therapeutics : nomination committee for the AGM 2021	30/20/30	AQ
Calliditas Therapeutics' : nomination committee for the AGM 2021	27/20/27	AQ
Calliditas Therapeutics AB Appoints Jonathan Schur as Group General Counsel	25/20/25	CI
Calliditas Therapeutics AB Announces Executive Changes	24/20/24	CI
Calliditas Therapeutics AB Elects Molly Henderson as Member of the Board of Directors	25/20/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Insiders

Filters